P53 targeting therapeutic (Congruence Therapeutics)

N/A

Report date: 2025/06/11 10:49:35
NME

Base Information

Drug NameP53 targeting therapeutic (Congruence Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionTumor protein p53 modulators
TargetsTumor protein p53
Therapy Area/IndicationsSolid tumoursHematologic NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCongruence Therapeutics Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A